inThought offers market data, analysis and forecasting from a single source
BRIDGEWATER, N.J., June 29 /PRNewswire/ -- Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry, today introduced Wolters Kluwer Health inThought(TM), a new market research service that offers an array of pharmaceutical forecasting capabilities. inThought was developed to help financial analysts, health care suppliers and drug makers understand where developmental drugs, medical devices, and therapies are positioned today and where they are likely headed in the future.
inThought is among the first of a new generation of research services that can deliver data, analysis and forecasting from a single source, an approach that is both cost effective and helps streamline the market research process. inThought integrates Wolters Kluwer Health's trusted clinical, prescription, managed markets, and patient information -- recognized to be of the highest quality in the industry -- together with the keen insight and forecasting abilities developed by a team of highly skilled individuals including researchers, analysts and physicians.
"With research headcounts down, there's a fundamental shift in the way analysts and pharma customers want their research delivered," said Ben Weintraub, Director of Research, Wolters Kluwer Health inThought. "Rather than simply striving to offer more data faster, our approach sifts through the clutter to synthesize what is truly important."
Customers now have all of the tools they need from a single, independent source to aid them in making more efficient decisions about their products, markets and competitors. inThought's progressive approach benefits from the wealth of knowledge and experience provided by Wolters Kluwer Health Phar
|SOURCE Wolters Kluwer Health|
Copyright©2009 PR Newswire.
All rights reserved